Egr-1 upregulates the Alzheimer's disease presenilin-2 gene in neuronal cells.

Regulation of the Alzheimer's disease (AD)-related gene, presenilin-2 (PSEN2), was analyzed in neuronal (SK-N-SH) and non-neuronal (human embryonic kidney 293, HEK293) cells. We show that the PSEN2 regulatory region includes two separate promoter elements, each located upstream of multiple transcription start sites in the first and second exons. The stronger upstream promoter, P1, has housekeeping characteristics: it resides in a CpG island, is TATA-less, and up to 83% of PSEN2-P1 activity depends on a stimulating protein 1 (Sp1) site at the most 5' initiation site. However, the downstream promoter P2 includes neuronal-specific elements and two sites for early growth response gene-1 (Egr-1), a transcription factor upregulated in learning paradigms and implicated in neuronal plasticity, in response to injury. We show that Egr-1 binds to PSEN-P2, and that PSEN-P2 activity is increased threefold by overexpression of Egr-1, and by 12-O-tetradecanoylphorbol-13-acetate (TPA), which induces physiological Egr-1 levels. Egr-1 represses PSEN2-P1 activity by 50% in neuronal cells, suggesting it partially shifts promoter usage from PSEN2-P1 to PSEN2-P2. This could lead to a relative increase in shorter exon 2 transcripts, which may be more efficiently translated than exon 1 transcripts. Identification of PSEN2 as an Egr-1 target suggests a link between PSEN2 expression and Egr-1-related processes, which may impact on understanding PSEN-2's physiological function and its role in Alzheimer's disease.

[1]  C. McCoy,et al.  12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1 , 1995, Molecular and cellular biology.

[2]  M. Mattson,et al.  Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  T. Werner,et al.  Highly specific localization of promoter regions in large genomic sequences by PromoterInspector: a novel context analysis approach. , 2000, Journal of molecular biology.

[4]  Ruo-Pan Huang,et al.  Reciprocal modulation between Sp1 and Egr‐1 , 1997, Journal of cellular biochemistry.

[5]  D. Walker,et al.  Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer's disease brains , 1997, Brain Research.

[6]  N. Sato,et al.  Activated cAMP-response Element-binding Protein Regulates Neuronal Expression of Presenilin-1* , 2001, The Journal of Biological Chemistry.

[7]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[8]  F. Nicoletti,et al.  An enhanced expression of the immediate early gene, Egr-1, is associated with neuronal apoptosis in culture , 1999, Neuroscience.

[9]  R. Fuldner,et al.  Cloning and characterization of the presenilin-2 gene promoter. , 1998, Brain research. Molecular brain research.

[10]  D. Dorsa,et al.  Specific downregulation of presenilin 2 gene expression is prominent during early stages of sporadic late-onset Alzheimer's disease. , 2000, Brain research. Molecular brain research.

[11]  C. Masters,et al.  Presenilin 2 expression in neuronal cells: induction during differentiation of embryonic carcinoma cells. , 2000, Experimental cell research.

[12]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.

[13]  Kuroda,et al.  Constitutive and cytokine‐regulated expression of presenilin‐1 and presenilin‐2 genes in human neural cell lines , 1999, Neuropathology and applied neurobiology.

[14]  G. Schellenberg,et al.  Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer disease gene. , 1996, Genomics.

[15]  D. Israeli,et al.  Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression , 1998, Nature Medicine.

[16]  C. Broeckhoven,et al.  Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility. , 2000, Human molecular genetics.

[17]  Xiaolong Wei,et al.  Alzheimer's disease-related gene expression in the brain of senescence accelerated mouse , 1999, Neuroscience Letters.

[18]  I. Kanazawa,et al.  Presenilin 1 mRNA expression in hippocampi of sporadic Alzheimer's disease patients , 1996, Neuroscience Research.

[19]  W. Tischmeyer,et al.  Activation of immediate early genes and memory formation , 1999, Cellular and Molecular Life Sciences CMLS.

[20]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[21]  L. Lannfelt,et al.  Quantification of presenilin‐1 mRNA in Alzheimer's disease brains , 1996, FEBS letters.

[22]  E. Rogaev,et al.  Presenilin-2 (PS2) expression up-regulation in a model of retinopathy of prematurity and pathoangiogenesis , 2001, Neuroreport.

[23]  N. Shaper,et al.  The increased level of beta1,4-galactosyltransferase required for lactose biosynthesis is achieved in part by translational control. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Abrous,et al.  Effect of aging on the basal expression of c-fos, c-jun, and egr-1 proteins in the hippocampus , 1997, Neurobiology of Aging.

[25]  J. Baraban,et al.  The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience , 1999, Trends in Neurosciences.

[26]  C. Cotman,et al.  Gene expression of Alzheimer‐associated presenilin‐2 in the frontal cortex of Alzheimer and aged control brain , 1996, FEBS letters.

[27]  H. Lester,et al.  Modulation of early growth response (EGR) transcription factor-dependent gene expression by using recombinant adenovirus. , 2000, Gene.

[28]  C. Duijn,et al.  Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression. , 2000, Human molecular genetics.

[29]  M. Kozak,et al.  Do the 5'untranslated domains of human cDNAs challenge the rules for initiation of translation (or is it vice versa)? , 2000, Genomics.

[30]  H. Das,et al.  Regulation of Transcription of the Human Presenilin-1 Gene by Ets Transcription Factors and the p53 Protooncogene* , 2000, The Journal of Biological Chemistry.